Enalaprilat

Congestive Heart Failure, Diabetic Nephropathies, Ventricular Dysfunction, Left + 1 more

Treatment

20 Active Studies for Enalaprilat

What is Enalaprilat

Enalaprilat

The Generic name of this drug

Treatment Summary

Enalaprilat is a medication used to treat high blood pressure. It works by preventing an enzyme called Angiotensin Converting Enzyme (ACE) from turning angiotensin I into angiotensin II, which can cause vasoconstriction and sodium reabsorption in the kidneys. Enalaprilat was developed to reduce side effects and the metallic taste that some patients experienced with captopril, the first ACE inhibitor. The active ingredient in enalaprilat is not easily absorbed through the digestive system, so it is only available as an intravenous injection.

Enalaprilat

is the brand name

Enalaprilat Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Enalaprilat

Enalaprilat

2000

12

Effectiveness

How Enalaprilat Affects Patients

Enalaprilat injection quickly reduces both systolic and diastolic blood pressure, usually without causing lightheadedness. The effects usually start within 15 minutes, with the maximum effect occurring between 1-4 hours after administration. The effects usually last around 6 hours, but this may vary depending on the dose given. Enalapril also increases blood flow to the kidneys, but usually does not change the rate of filtration. This is also the case in patients with high blood pressure caused by kidney problems.

How Enalaprilat works in the body

Enalaprilat is a medicine used to treat high blood pressure. It works by blocking an enzyme called Angiotensin Converting Enzyme (ACE). This enzyme is responsible for making a protein called angiotensin II, which narrows your blood vessels and causes the body to keep more salt. By blocking ACE, enalaprilat reduces the amount of angiotensin II in your body, which helps lower your blood pressure and reduce the amount of fluid in your blood.

When to interrupt dosage

The sum of Enalaprilat depends on the diagnosed condition, including Left Ventricular Dysfunction, Diabetic Nephropathy and Hypertensive disease. The amount of dosage is contingent upon the technique of delivery outlined in the table below.

Condition

Dosage

Administration

Congestive Heart Failure

, 2.5 mg/mL, 1.25 mg/mL

, Intravenous, Injection, Injection - Intravenous, Injection, solution, Injection, solution - Intravenous, Solution - Intravenous, Solution

Ventricular Dysfunction, Left

, 2.5 mg/mL, 1.25 mg/mL

, Intravenous, Injection, Injection - Intravenous, Injection, solution, Injection, solution - Intravenous, Solution - Intravenous, Solution

Diabetic Nephropathies

, 2.5 mg/mL, 1.25 mg/mL

, Intravenous, Injection, Injection - Intravenous, Injection, solution, Injection, solution - Intravenous, Solution - Intravenous, Solution

Hypertensive disease

, 2.5 mg/mL, 1.25 mg/mL

, Intravenous, Injection, Injection - Intravenous, Injection, solution, Injection, solution - Intravenous, Solution - Intravenous, Solution

Warnings

Enalaprilat has three contraindications and should not be taken when facing any of the issues outlined in the table below.

Enalaprilat Contraindications

Condition

Risk Level

Notes

Angioedema

Do Not Combine

Angioedema

Do Not Combine

Angioedema

Do Not Combine

There are 20 known major drug interactions with Enalaprilat.

Common Enalaprilat Drug Interactions

Drug Name

Risk Level

Description

Amifostine

Major

Enalaprilat may increase the hypotensive activities of Amifostine.

Azathioprine

Major

The risk or severity of myelosuppression, anemia, and severe leukopenia can be increased when Enalaprilat is combined with Azathioprine.

Sacubitril

Major

The risk or severity of angioedema can be increased when Enalaprilat is combined with Sacubitril.

Sodium aurothiomalate

Major

The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Enalaprilat is combined with Sodium aurothiomalate.

Acrivastine

Minor

Enalaprilat may decrease the excretion rate of Acrivastine which could result in a higher serum level.

Enalaprilat Toxicity & Overdose Risk

Taking enalaprilat may cause side effects such as heart attack, tiredness, dizziness, fever, rash, and constipation. It can also lead to a more serious issue called angioedema (swelling of the face, lips, tongue, throat, etc.) which can be fatal. Other rarer side effects include anaphylaxis, low blood pressure, low white blood cells, liver failure, high potassium levels, and persistent coughing. Enalaprilat should not be taken during pregnancy as it can cause injury or death to the fetus or newborn.

Enalaprilat Novel Uses: Which Conditions Have a Clinical Trial Featuring Enalaprilat?

331 active studies are currently analyzing the potential of Enalaprilat to alleviate Diabetic Nephropathy, Congestive Heart Failure and Hypertensive diseases.

Condition

Clinical Trials

Trial Phases

Hypertensive disease

27 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3

Diabetic Nephropathies

0 Actively Recruiting

Ventricular Dysfunction, Left

0 Actively Recruiting

Congestive Heart Failure

184 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3, Early Phase 1

Enalaprilat Reviews: What are patients saying about Enalaprilat?

5

Patient Review

1/12/2016

Enalaprilat for High Blood Pressure

I've been taking this medication for three years and, while it has helped regulate my blood pressure, I have started to experience a number of unpleasant side effects. These include sweating, fatigue, coughing, low sex drive, and general feelings of malaise.

5

Patient Review

2/23/2015

Enalaprilat for High Blood Pressure

I discontinued using this medication after it made me cough a lot and I ended up in bed.

5

Patient Review

10/24/2018

Enalaprilat for High Blood Pressure

I've been on Enalapril for over a decade now, and it's done wonders for my blood pressure. I started out taking just 10 mg once per day, but found that by evening my BP had gone up again. So, I changed the dosage to 10mg twice a day and later increased it to 15mg twice a day. This has worked very well for me with no negative side effects whatsoever.

5

Patient Review

12/18/2014

Enalaprilat for High Blood Pressure

I sometimes experience severe dizziness after taking this medication, but it does go away quickly.

5

Patient Review

5/15/2014

Enalaprilat for Chronic Heart Failure

5

Patient Review

5/22/2017

Enalaprilat for High Blood Pressure

So I switched from hydrochlorothiazide to enalapril 2.5 mg a week ago because the former was giving me hives, numbness in my arms and hands, knee pain, and severe headaches. So far the results have been great—my blood pressure has gone down from 150/96 to 106/76.

5

Patient Review

10/24/2018

Enalaprilat for High Blood Pressure

I've been taking Enalapril for over a decade now, and it's been great. I originally started on 10 mg once per day, but found that my blood pressure would go up by evening. So, I changed the dosage to 10mg twice a day and later increased it to 15 mg twice a day. It works really well for me with no negative side effects whatsoever.

5

Patient Review

5/15/2014

Enalaprilat for Chronic Heart Failure

5

Patient Review

12/18/2014

Enalaprilat for High Blood Pressure

I sometimes experience severe dizziness after taking this medication, but it does go away quickly.

5

Patient Review

2/23/2015

Enalaprilat for High Blood Pressure

I used this medication in conjunction with another, but it made me so cough badly that I had to discontinue both. Now I'm thinking I might just need to use the enalapril 5 mg tablet as prescribed halve tab twice daily.

5

Patient Review

1/12/2016

Enalaprilat for High Blood Pressure

I've been taking this treatment for three years and it has effectively kept my blood pressure in check. However, I am starting to experience some unpleasant side effects, such as sweating, fatigue, low sex drive, and shortness of breath.

5

Patient Review

5/22/2017

Enalaprilat for High Blood Pressure

I switched from hydrochlorothiazide to enalapril 2.5 mg a week ago because the former was giving me hives, numbness in both arms and hands, knee pain, and severe headaches. So far the results have been great; my blood pressure has gone from 150/96 to 106/76.

4.7

Patient Review

7/12/2014

Enalaprilat for Kidney Disease from Diabetes

This medication has improved my dog's quality of life immensely. He's a senior dog with an enlarged heart, and this medication has made it much easier for him to breathe.

4.7

Patient Review

7/12/2014

Enalaprilat for Kidney Disease from Diabetes

This medication has helped my dog "Ted" a lot. He's a senior dog with an enlarged heart, and this med helps him breathe easier. It's made his life (and mine) much nicer.

4

Patient Review

5/23/2020

Enalaprilat for High Blood Pressure

I've been taking this medication for over 15 years to help control my blood pressure. It's not perfect, but when combined with another high blood pressure medication, it's been very effective for me with few side effects.

4

Patient Review

5/23/2020

Enalaprilat for High Blood Pressure

I've been on this medication for over 15 years. It's not perfect, but adding it to another high blood pressure medication has allowed me to control my blood pressure without the horrible side-effects I've experienced with other medications.

3.7

Patient Review

7/26/2014

Enalaprilat for High Blood Pressure

I was taking this medication and it led to some really severe coughing fits. It got to the point where my chest and stomach would hurt from all the hacking. Once I looked up the side effects and saw that this was a common one, I stopped taking it and haven't had any issues since.

3.7

Patient Review

7/26/2014

Enalaprilat for High Blood Pressure

This medication gave me really severe coughing fits. Once I did some research and found out that this was a common side effect, I stopped taking it and haven't had any issues since.

3.3

Patient Review

3/21/2017

Enalaprilat for High Blood Pressure

This medication does a great job of lowering my blood pressure. I was struggling to keep it normal with other medications, but this one has really helped me out.

3.3

Patient Review

4/15/2015

Enalaprilat for High Blood Pressure

I didn't see the results I was hoping for when taking this drug in combination with Atenolol. My blood pressure remained unchanged.

3.3

Patient Review

4/15/2015

Enalaprilat for High Blood Pressure

I didn't see the results I was hoping for when taking this drug in combination with Atenolol.

3.3

Patient Review

3/21/2017

Enalaprilat for High Blood Pressure

This medication is much better at regulating my blood pressure. I was taking labetalol and amlodipine before this, but even with those it was difficult to maintain a normal blood pressure. With this medication, though, I'm able to have a more normal range.

3

Patient Review

5/24/2014

Enalaprilat for High Blood Pressure

3

Patient Review

5/24/2014

Enalaprilat for High Blood Pressure

2.7

Patient Review

4/22/2017

Enalaprilat for High Blood Pressure

I started taking enalapril because I had a bad experience with amlodipine. At first, this drug was great. My blood pressure was normal and I didn't have any side effects. But after a couple of weeks, I developed a dry cough that kept me up at night. It got worse and worse until I couldn't take it anymore and stopped taking the drug after 5 months.

2.7

Patient Review

6/21/2014

Enalaprilat for High Blood Pressure

2.7

Patient Review

6/21/2014

Enalaprilat for High Blood Pressure

2.7

Patient Review

4/22/2017

Enalaprilat for High Blood Pressure

I had to switch to enalapril from amlodipine because of how terrible the latter was. At first, this new drug was great! My blood pressure lowered and I experienced no adverse effects. However, after a few weeks I developed a dry cough that made it impossible for me to sleep. This continued to worsen until I just couldn't take it anymore and stopped taking the medication altogether.

2.3

Patient Review

6/3/2018

Enalaprilat for High Blood Pressure

I didn't have a good experience with this medication. I felt very out of it and exhausted while taking it, and it made me feel like I was drunk all the time. My blood pressure did stay low, but the side effects weren't worth it for me.

2.3

Patient Review

7/16/2018

Enalaprilat for High Blood Pressure

I've been on this medication for a few months now. It caused me to cough a little bit at first, but that went away relatively quickly. My main worry now is the significant increase in my waist size; even though I haven't gained any weight, my pants are much tighter than before. Has anyone else experienced this side effect?

2.3

Patient Review

3/23/2015

Enalaprilat for High Blood Pressure

This medication helps to control my blood pressure.

2.3

Patient Review

3/23/2015

Enalaprilat for High Blood Pressure

Helps to manage my blood pressure.

2.3

Patient Review

6/3/2018

Enalaprilat for High Blood Pressure

I found that the mental fogginess and fatigue were too much for me to handle after only taking this drug for a short while. It did keep my blood pressure low, but I stopped taking it because I didn't feel like it was worth the side effects.

2.3

Patient Review

7/16/2018

Enalaprilat for High Blood Pressure

I've been on this medication for a while now, and at first it caused me to cough a bit. However, my bigger worry is that I seem to be gaining inches around my waistline, even though I haven't gained any weight. Has anyone else experienced this side effect?

1.7

Patient Review

10/18/2018

Enalaprilat for Dysfunction of Left Ventricle of Heart Without Symptoms

I took this medication for two months and experienced a range of negative side effects, including a bad cough, dizziness, headaches, insomnia, and extreme dry mouth. While it did lower my blood pressure as intended, the side effects were not worth it in my opinion.

1.7

Patient Review

10/18/2018

Enalaprilat for Dysfunction of Left Ventricle of Heart Without Symptoms

I took this medication for two months and experienced a whole host of negative side-effects, like a bad cough, dizziness when standing up, headaches, insomnia, and extreme dry mouth. It did lower my blood pressure as intended but the trade-off wasn't worth it for me.

1

Patient Review

4/7/2020

Enalaprilat for High Blood Pressure

I had such bad heart palpitations that I couldn't sleep, and it also resulted in asthma. This treatment did nothing to help my blood pressure, but luckily I found some relief from natural B vitamins and regular exercise. Even though those things helped, I still have asthma; thanks doc!

1

Patient Review

5/14/2014

Enalaprilat for Prevention of Recurrent Atrial Fibrillation

1

Patient Review

5/14/2014

Enalaprilat for Prevention of Recurrent Atrial Fibrillation

1

Patient Review

4/7/2020

Enalaprilat for High Blood Pressure

I had such severe heart palpitations that it resulted in asthma and breathing problems. This treatment did little to relieve my blood pressure. However, I take NATURAL B vitamins and exercise regularly, which has helped me get my blood pressure back to normal.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about enalaprilat

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enalaprilat the same as enalapril?

"The drug enalaprilat is the active form of the medication enalapril, which is taken orally. Enalapril is used to treat hypertension, and works by preventing the enzyme ACE from turning angiotensin I into angiotensin II."

Answered by AI

How do you give an enalaprilat injection?

"The administration of enalaprilat injection should be done slowly through an IV, as indicated above. It can be administered directly, or diluted with a compatible diluent up to 50 mL."

Answered by AI

When do you use enalaprilat?

"This medication is used to treat high blood pressure. By lowering your blood pressure, it helps reduce your risk of developing heart disease, stroke, or kidney problems."

Answered by AI

Is enalaprilat an ACE inhibitor?

"Fosinopril (Monopril) Lisinopril (Priopril)

There are several types of ACE inhibitors, including Benazepril, Captopril, Enalapril, Fosinopril, and Lisinopril."

Answered by AI

Clinical Trials for Enalaprilat

Image of Columbia University in New York, United States.

MediBeacon Transdermal GFR System for Heart Failure

18+
All Sexes
New York, NY

The goal of this clinical trial is to evaluate the accuracy and feasibility of transdermal glomerular filtration rate (tGFR) assessment using relmapirazin (Lumitrace) and the MediBeacon tGFR system compared to plasma clearance measurement of GFR in adults with heart failure. The main question it aims to answer is the comparison of the transdermal-derived GFR for each participant using the MediBeacon tGFR to their nGFRBSA measurement. Participants will participate in a Screening visit that will take place within 15 days of the scheduled administration of Lumitrace and iohexol. On dosing day, participants will have the tGFR reusable sensor with disposable adhesive ring placed on their chest, and the MediBeacon Transdermal GFR System initiated to collect background fluorescence. Following an injection of Lumitrace and iohexol and the initiation of GFR assessments, participants will be followed at the study center for 10-24 hours. All participants will participate in a follow-up phone call approximately 7 days after the last exposure to Lumitrace and iohexol. Researchers will analyze the results to compare the tGFR values to the nGFRBSA measurements for each participant.

Waitlist Available
Has No Placebo

Columbia University

Richard B Dorshow, PhD

MediBeacon

Image of Mass General Brigham in Boston, United States.

Clinical Decision Support Tool for Heart Failure

18 - 85
All Sexes
Boston, MA

This study is an investigator-initiated, cluster-randomized implementation trial evaluating a large language model (LLM)-based clinical decision support (CDS) tool designed to improve guideline-directed medical therapy (GDMT) for adult patients with heart failure seen in outpatient cardiology clinics at Mass General Brigham. For eligible heart failure encounters, the CDS tool reviews existing electronic health record (EHR) data, including diagnoses, medications, vital signs, laboratory results, and recent notes, and generates brief, clinician-facing messages suggesting opportunities to initiate or optimize GDMT and highlighting relevant safety considerations. Messages are delivered to cardiology providers via Epic InBasket and/or institutional email prior to scheduled visits. The tool is advisory only and cannot place orders or change medications automatically; all treatment decisions remain at the discretion of the treating clinician and patient. Cardiology providers are assigned at the provider/clinic level to early implementation of the CDS tool versus usual care (no messages) during the initial phase. The primary outcome is GDMT optimization within 30 days of an index visit. Secondary outcomes include feasibility of CDS generation and delivery and a 30-day safety composite (e.g., heart failure hospitalization, acute kidney injury, hyperkalemia, hypotension or bradyarrhythmia plausibly related to GDMT).

Waitlist Available
Has No Placebo

Mass General Brigham

Image of Miles Square Health Center Chicago in Chicago, United States.

Food is Medicine for High Blood Pressure and Obesity

Any Age
All Sexes
Chicago, IL

The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?

Phase 2
Waitlist Available

Miles Square Health Center Chicago (+3 Sites)

Image of Seaway Valley Community Health Centre (Cardiac Rehab Program) in Cornwall, Canada.

FRAME for Heart Failure

18+
All Sexes
Cornwall, Canada

Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives. Despite this interconnection, the integration of mental health awareness and support into cardiac care remains limited. To address this gap, the FRAME (Foundation, Recognition, Awareness, Management, Engagement) intervention was co-designed by researchers, healthcare providers, health system decisionmakers, and patient partners. This pilot study evaluates the feasibility of implementing the FRAME intervention in pilot clinical sites within two health regions in Ontario, Canada, including team-based family medicine clinics, cardiac rehabilitation/specialist clinics, and emergency departments. Utilizing a pretest-posttest hybrid 1 model intervention design, this study evaluates process indicators and patient-focused outcomes through surveys and semi-structured qualitative interviews. Findings from this study will inform a future large scale cohort study and scalable integration of the FRAME tool into existing cardiac care pathways to enhance mental health awareness and support among heart failure patients.

Recruiting
Has No Placebo

Seaway Valley Community Health Centre (Cardiac Rehab Program) (+8 Sites)

Have you considered Enalaprilat clinical trials?

We made a collection of clinical trials featuring Enalaprilat, we think they might fit your search criteria.
Go to Trials
Image of Yale New Haven Hospital-St. Raphael Campus in New Haven, United States.

Dapagliflozin for Heart Failure

18 - 85
All Sexes
New Haven, CT

The overall objective of this study is to determine whether the addition of SGLT2 inhibitors to usual care in hospitalized patients with heart failure associated acute kidney injury is safe and efficacious. Investigators will assess if SGLT2 inhibition improves a composite cardio-renal outcome (mortality, dialysis, AKI progression, decongestion metrics, heart failure symptoms). Secondary objectives of this study are to compare individual components of the composite outcome as well as changes in biomarkers of kidney injury, inflammation, repair and oxidative stress between those exposed to the SGLT2 inhibitor vs placebo.

Phase 2
Waitlist Available

Yale New Haven Hospital-St. Raphael Campus (+1 Sites)

Abinet Aklilu, MD

Image of Cambride Cardiac Care Centre in Cambridge, Canada.

Finerenone for Heart Failure

18+
All Sexes
Cambridge, Canada

The goal of this clinical trial is to learn if the drug finerenone (Karendia) can improve heart function in participants who are at risk for heart and kidney disease. The main question it aims to answer is whether adding finerenone to standard-of-care heart failure medical therapies will beneficially alter the heart structure and function of people who have risk factors for heart and kidney complications and whose left side of the heart is enlarged. The researchers will compare finerenone to a placebo (a look-alike substance that contains no drug) to see if finerenone improves heart structure and function. Participants will: * take a finerenone or a placebo tablet once a day for 12 months * have a cardiac magnetic resonance imaging (cMRI; a safe, non-invasive scan to measure heart mass, stiffness and function) test at the beginning of the study and 12 months later * visit the clinic after one, three, six and twelve months to assess overall health and/or perform blood or urine tests

Phase 3
Waitlist Available

Cambride Cardiac Care Centre (+2 Sites)

Subodh Verma, MD, PhD

Bayer

Image of Lakeland Regional Hospital in Lakeland, United States.

Furosemide for Heart Failure

18+
All Sexes
Lakeland, FL

The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care. The main questions it aims to answer are: 1. Does targeting a higher urine sodium goal achieve greater natriuresis and diuresis? 2. Does targeting a higher urine sodium goal reduce frequency of hospital readmissions? 3. Does targeting a higher urine sodium goal reduce hospital length of stay? Researchers will compare natriuresis-guided arms with standard of care to see if targeting higher natriuresis goals improves significantly over current practice. Participants will submit urine samples at routine intervals after being given diuretics to evaluate urine sodium concentration. If urine sodium is low then diuretic dose will be increased.

Phase 4
Waitlist Available

Lakeland Regional Hospital

Anas Bizanti, MD

Have you considered Enalaprilat clinical trials?

We made a collection of clinical trials featuring Enalaprilat, we think they might fit your search criteria.
Go to Trials
Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL

This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.

Waitlist Available
Has No Placebo

U Health (+1 Sites)

Ziad Zoghby, M.D., M.B.A.

Biobeat Technologies Ltd.

Have you considered Enalaprilat clinical trials?

We made a collection of clinical trials featuring Enalaprilat, we think they might fit your search criteria.
Go to Trials